About ASH Annual Meeting 2026 New Orleans
ASH Annual Meeting draws tens of thousands of hematology and blood disorder professionals and features hundreds of exhibitors spanning targeted hematology and blood cancer pharmaceutical therapies, cell and gene therapy platforms, clinical laboratory diagnostics and hematology analyzers, bone marrow biopsy and interventional hematology technology, patient monitoring and minimal residual disease detection platforms, clinical trial management and research operations software, and medical education and hematology publishing organizations.
This is one of the most scientifically credentialed and evidence-demanding audiences in all of medical trade shows: board-certified hematologists, blood cancer research scientists, and cell and gene therapy investigators who evaluate pharmaceutical therapies and medical technology against the most rigorous standards of clinical evidence, molecular biology, and regulatory compliance in the hematology specialty.
Who Attends?
Hematology and blood disorder research and clinical professionals across functions, including:
- Medical Hematologists and Blood Cancer Subspecialty Specialists
- Hematologic Oncology Research Scientists and Principal Investigators
- Cell and Gene Therapy Researchers and Clinical Program Directors
- Hematopathologists and Molecular Diagnostics Specialists
- Clinical Laboratory Directors and Hematology Analyzer Specialists
- Bone Marrow Transplant and Cellular Therapy Program Leaders
- Oncology Pharmacists and Hematology Clinical Pharmacy Directors
- Academic Medical Center Department Chiefs and Hematology Fellowship Program Directors
Attendees come from academic medical centers, comprehensive cancer centers, hematology subspecialty practices, national laboratories, government research agencies, bone marrow transplant programs, and international hematology research organizations from across the United States and globally.
Who Exhibits?
ASH Annual Meeting attracts pharmaceutical companies, medical device manufacturers, and research technology providers across the full hematology and blood disorder ecosystem, including:
- Targeted hematology therapy, CAR-T, and bispecific antibody pharmaceutical manufacturers
- Cell and gene therapy platform and viral vector technology companies
- Hematology analyzers, flow cytometry, and clinical laboratory diagnostic technology providers
- Minimal residual disease detection and molecular monitoring platform companies
- Bone marrow biopsy, interventional hematology, and apheresis technology manufacturers
- Clinical trial management, electronic data capture, and hematology research operations platforms
- Patient support, access, and hematology disease awareness program organizations
- Medical education, hematology publishing, and research database service providers
Why Choosing the Right Booth Builders for ASH Annual Meeting 2026 New Orleans Matters
ASH Annual Meeting is not a show where a generic booth will serve you well. Booth builders for ASH Annual Meeting 2026 New Orleans need to understand how hematologists, blood cancer researchers, and cell and gene therapy specialists evaluate pharmaceutical therapies and medical technology through late-breaking clinical trial evidence presentations, mechanism of action demonstrations rooted in hematologic molecular biology, regulatory compliance conversations, and discussions grounded in the evidentiary standards of the hematology research community at its most scientifically demanding.
Blood cancer research expo exhibits carry a specific and demanding set of requirements that general exhibit contractors rarely anticipate. The pharmaceutical therapies and cell and gene therapy platforms being exhibited at ASH Annual Meeting are among the most scientifically complex and rapidly evolving products in all of medicine, evaluated by an audience that includes the scientists who designed the clinical trials, the investigators who enrolled the patients, and the hematologists who will make prescribing decisions based on the data being presented in the halls of the same convention center where the exhibition floor operates.
The contrast with other professional trade shows makes this clear. Booth builders for AWS re:Invent are designing for cloud computing engineers, software architects, and technology platform decision-makers in a commercially energetic, innovation-driven technology conference environment where live cloud platform demonstrations, developer experience, and technical architecture storytelling drive exhibit performance.
ASH Annual Meeting demands an entirely different approach: clinical evidence authority, regulatory compliance precision, and the scientifically restrained design environment that communicates to a hematologist or cell and gene therapy investigator that the exhibiting company operates to the evidentiary and ethical standards of the hematology research community.
What to Look for in ASH Annual Meeting Booth Builders
When evaluating ASH Annual Meeting exhibit builders, look for teams with direct experience in hematology pharmaceuticals, blood cancer medical devices, cell and gene therapy, or academic hematology research conference environments, and a demonstrated ability to build exhibits that communicate clinical evidence authority while meeting the regulatory requirements governing pharmaceutical and medical device promotion in a world-class hematology conference setting.
Prioritize these capabilities:
- Experience with hematology trade show booth design and blood cancer pharmaceutical, cell and gene therapy, or academic hematology research conference exhibition environments
- Ability to integrate compliant clinical trial data presentations, molecular mechanism of action displays, and medical information stations into booth architecture consistent with applicable FDA promotional guidelines
- Scientifically authoritative design aesthetics that reflect the clinical evidence standards and research integrity values of the hematology and blood cancer research community
- Layout planning that supports both efficient hematologist engagement during limited exposition floor time and deeper clinical conversation for engaged key opinion leaders, principal investigators, and cell and gene therapy program leaders
- Familiarity with Ernest N. Morial Convention Center operations in New Orleans, union labor requirements, and move-in scheduling for hematology pharmaceutical and cell therapy exhibit builds
Hematology Trade Show Booth Design
Effective hematology trade show booth design at ASH Annual Meeting does more than organize blood cancer pharmaceutical therapies and hematology diagnostics on a convention floor. It communicates that your company understands the molecular complexity of hematologic disease, the clinical evidence standards by which hematologists evaluate every therapy they consider for their patients, and the transformative potential of cell and gene therapy platforms that the ASH scientific community is actively investigating and clinically implementing in real patient populations.
At the ASH Annual Meeting, the design challenge is scientific credibility combined with regulatory compliance precision. A hematologist or cell and gene therapy investigator walking the exposition floor between scientific sessions may decide almost instantly whether a pharmaceutical or medical technology booth reflects the scientific depth and regulatory integrity that the hematology research community demands.
Well-designed blood cancer research expo exhibits at ASH Annual Meeting typically include:
- Compliant clinical trial efficacy and safety data displays for hematology therapies presented consistently with FDA promotional guidelines and applicable oncology regulatory standards
- Molecular mechanism of action and hematologic disease pathway visualization displays presenting the scientific rationale of CAR-T, bispecific antibody, and targeted hematology therapy platforms with accuracy and regulatory balance
- Medical information stations staffed and designed to support compliant on-label hematology clinical conversations with blood cancer specialists and cell and gene therapy program leaders
- Enclosed or semi-enclosed meeting areas for detailed key opinion leader discussions, principal investigator meetings, and clinical evidence review conversations with hematology department chiefs.
- Regulatory fair balance and comprehensive safety information integrated appropriately and prominently throughout all visual and digital displays within the booth environment.
Cell and Gene Therapy Booth Contractors and the Demands of Hematology Pharmaceutical Exhibits
Cell and gene therapy booth contractors understand that at ASH Annual Meeting, the scientific and regulatory credibility of the exhibit environment is not a design objective to be balanced against aesthetic or commercial considerations; it is the fundamental prerequisite on which the entire commercial engagement strategy of every hematology pharmaceutical exhibitor must be built.
Beyond the regulatory compliance foundation, cell and gene therapy booth contractors working at ASH Annual Meeting face significant technical and clinical design challenges specific to the hematology and cell therapy category. CAR-T cell therapy platform demonstrations require visualization environments that communicate the manufacturing process, patient selection criteria, and clinical administration pathway in ways that hematology program directors and transplant specialists can assess for institutional implementation.
Well-designed clinical diagnostics display booths at ASH Annual Meeting typically incorporate:
- Compliant blood cancer clinical trial efficacy, safety, and patient-reported outcome data displays presented consistently with FDA hematology oncology promotional standards
- CAR-T cell therapy, bispecific antibody, and targeted hematology therapy mechanism of action visualizations grounded in molecular hematology biology and presented with regulatory accuracy and balance
- Hematology analyzer, flow cytometry, and minimal residual disease detection platform demonstration environments with live instrument interfaces and clinical data visualization capability
- Medical information stations with appropriate fair balance infrastructure, on-label clinical conversation support, and hematology medical affairs team integration
- Key opinion leader, principal investigator, and cell and gene therapy program director meeting rooms with full presentation capability for detailed clinical evidence review and research collaboration discussions
Venue Considerations: Ernest N. Morial Convention Center and the ASH New Orleans Environment
Hematology pharmaceutical and cell and gene therapy exhibit builds at the Ernest N. Morial Convention Center require particular advance coordination around electrical capacity for clinical data display environments and AV infrastructure, specialized freight handling for sensitive hematology diagnostic instruments and cell therapy demonstration equipment, and regulatory display compliance review timelines that add significant pre-show planning requirements beyond those of a standard technology or consumer trade show exhibit.
Experienced ASH Annual Meeting booth builders come prepared with:
- Working knowledge of Ernest N. Morial Convention Center union labor agreements for installation and dismantling in New Orleans
- Advance electrical and AV planning for clinical trial data display environments, molecular mechanism of action visualization systems, and medical information station infrastructure
- Specialized freight handling coordination for sensitive hematology analyzer, flow cytometry, and cell therapy demonstration equipment shipments
- Regulatory display compliance planning and pre-show review coordination for hematology pharmaceutical and blood cancer medical device promotional materials
- ASH Annual Meeting move-in and move-out scheduling requirements and freight deadlines at the Ernest N. Morial Convention Center
Booth builders for WCIRDC face a comparable set of advanced venue planning and specialized compliance requirements in the workers' compensation and disability management conference environment, reinforcing the principle that venue readiness and specialized regulatory and logistics expertise in the build phase determine finished exhibit quality when the exposition floor opens.
How Exhibitorly Helps You Find the Right Booth Builders for ASH Annual Meeting 2026 New Orleans
Finding qualified contractors for ASH Annual Meeting typically starts with referrals within the hematology pharmaceutical industry or a general search that surfaces exhibit companies with no blood cancer research, hematology pharmaceutical, cell and gene therapy, or academic hematology conference experience. Comparing them efficiently is the hard part. Exhibitorly significantly reduces that effort.
Submit one project brief and receive proposals from multiple qualified booth builders for ASH Annual Meeting 2026 New Orleans, including contractors with direct experience in hematology booth design, blood cancer pharmaceutical exhibition, cell and gene therapy display environments, and academic hematology research conference trade show settings. You can compare design approaches, relevant experience, and pricing before committing to anyone.
Using Exhibitorly, exhibitors can:
- Compare multiple builders on one platform
- Request quotes with a single project brief
- Evaluate builders specifically on blood cancer research exhibits and hematology pharmaceutical, cell therapy, or blood cancer medical device conference trade show experience.
- Assess cell and gene therapy booth contractors on their demonstrated ability to build regulatory-compliant hematology pharmaceutical exhibition environments and clinical evidence display systems.
- Review design approaches, regulatory compliance capability, and New Orleans venue familiarity before committing
Exhibitorly is free for exhibitors. No upfront costs, no commitments.
Start Comparing ASH Annual Meeting Exhibit Builders
The regulatory complexity, scientific evidence standards, and cell and gene therapy demonstration requirements of clinical diagnostics display booths at ASH Annual Meeting mean lead times are significantly longer than most first-time hematology conference exhibitors expect.
The most experienced cell and gene therapy booth contractors with proven hematology pharmaceutical and blood cancer medical device exhibition capability book well in advance, and the compliance review timelines for hematology oncology promotional materials, the sensitivity of hematology diagnostic instrument shipments, and the evidentiary standards of the ASH scientific community add planning requirements that general exhibit contractors are entirely unprepared to navigate.
Booth builders for Abilities Expo face a similarly specialized pre-show planning process for a community-driven, mission-oriented professional audience in the disability products and services sector, underscoring that regardless of the industry, early contractor selection and thorough pre-show regulatory, technical, and logistical preparation are what separate a scientifically credible, regulatory-compliant, high-performing exhibit from one that falls short of the clinical and commercial opportunity that ASH Annual Meeting 2026 New Orleans represents.
Use Exhibitorly to compare qualified booth builders for ASH Annual Meeting 2026 New Orleans, request free quotes, and find an exhibit builder with real experience in blood cancer research exhibits, clinical diagnostics booths, and hematology booth design.
